Anesthetic management of patients receiving calculus therapy with a third-generation extracorporeal lithotripsy machine

We reviewed the anesthetic requirements for satisfactory use of a third-generation electromagnetic-source design for extracorporeal shockwave lithotripsy (SWL), Medical records were reviewed for a period of 9 months on all patients receiving anesthesia care for SWL with and without other urologic procedures, The Modulith(R) SL20 was used on 56 ASA Class I-III patients having 87 SWL treatments, Demographic and anesthetic variables were recorded, Complications documented included dysrhythmias, nausea necessitating treatment, and conversion from sedation to regional or general anesthesia, The majority of procedures (83%) were performed on an outpatient basis, Patients were classified as ASA physical status I(27%), II(63%), or III(10%), Monitored anesthesia care with intravenous sedation was utilized in 93% of cases, Of these cases, 78 involved a combination of intravenous propofol, fentanyl, and midazolam; the remaining 3 involved propofol, alfentanil, and/or midazolam, The mean treatment duration was 36 minutes, Patients were discharged within 1 hour after procedure completion in 77 cases (89%), Nausea necessitating treatment was rare (3%), The mean dose of propofol administered with SWL as the only procedure was 272 +/- 112 mg, When SWL was combined with other urologic procedures, the mean dose of propofol was 334 +/- 121 mg. Continuous intravenous propofol infusion provides excellent procedural conditions for SWL on the Modulith(R) SL120, a third-generation lithotripter.